Kenig's disease, also known as Perthes disease, is a rare genetic condition that leads to the development of painful tumors in the bones. It usually begins in adolescence and can lead to restricted movement and bone deformities.
Kenig's disease is caused by a mutation in the NOD2 gene, which controls the body's inflammatory response. This leads to excessive activation of osteoclasts, resulting in bone tissue destruction.
Diagnosis of Kenig's disease usually involves X-rays, computed tomography, or magnetic resonance imaging to assess the condition of the bones.
Treatment of Kenig's disease often involves the use of anti-inflammatory drugs, bisphosphonates, or surgical intervention for reconstruction or stabilization of affected bones.
Since Kenig's disease is a genetic condition, prevention involves genetic counseling and screening of relatives to identify the risk of developing the disease.
Treatment and monitoring of patients with Kenig's disease is conducted by a rheumatologist or orthopedic surgeon.
Note: This material is provided for informational purposes only and is not medical advice.